Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Variation in CYP2A6 Activity and Personalized Medicine

Journal of Personalized Medicine(2017)10.3390/jpm7040018Source: DataRank Database

Variation in CYP2A6 Activity and Personalized Medicine is a research paper published in Journal of Personalized Medicine (2017). On theSindex it has a DataRank of 0.771. It has been cited 170 times.

N/A

0.771DataRank · unranked

Scored on demand from live citation data

170 citations

Download PDF

Cite:

Linked data & code

refsnp

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (2 grants)Impact (FWCI 12.60)OA: goldTopics (28)Linked Datasets (10)DataCite Reuse (10)IDs (PubMed, PMC, OpenAlex)Annotations (1)SDGs (3)

FAIR Checklist

Context only (not used in score)

Findable (2/2)

Has DOI
Indexed in repositories

Accessible (0/2)

Interoperable (2/2)

DataCite relations
Linked datasets

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

DataRank Breakdown

Base Score 100%Citation Network 0%

Base Score Contribution

0.771

From this paper's citation signal

Citation Network Contribution

Citation network not refreshed for this result

This paper's DataRank is currently driven only by its base citation score. Citation network data was not refreshed for this result.

Learn more about DataRank methodology →

Authors (2)

Rachel Tyndale,Julie-Anne Tanner

Live enrichment

PubMed:29194389 PMC:PMC5748630 OpenAlex:https://openalex.org/W2774341657

Canadian Institutes of Health Research

Grant: unidentified

unidentified

This work was supported by a Canada Research Chair in Pharmacogenomics (R.F.T.), CIHR FDN-154294, and the Campbell Family Mental Health Research Institute of CAMH.

FWCI

12.60

Citation Percentile

1.0%

Citation Trend

2018

2019

2020

2021

2022

2023

2024

2025

2026

goldLicense: cc-by

journalhttps://www.mdpi.com/2075-4426/7/4/18/pdf?version=1512127289

publisherhttps://www.mdpi.com/2075-4426/7/4/18/pdf?version=1512127289

publisherhttps://www.mdpi.com/2075-4426/7/4/18/pdf

journalhttps://doi.org/10.3390/jpm7040018

repositoryhttps://pubmed.ncbi.nlm.nih.gov/29194389

Fields of Study

Pharmacogenetics and Drug MetabolismDrug Transport and Resistance MechanismsReceptor Mechanisms and Signaling0301 basic medicine03 medical and health sciences0302 clinical medicine

Keywords

CYP2A6NicotinePharmacologyMedicineCotinineCYP2B6Smoking cessationBiologyMetabolismCYP1A2Cytochrome P450Internal medicineInhibitorGenetic variationPharmacogenomicsInducerDrug metabolismSmokingSNPPharmacogenetics610Review

Sustainable Development Goals

SDG 3: 3. Good healthSDG 16: 16. Peace & justiceSDG 0: Good health and well-being

Additional file 1 of Universal probe-based intermediate primer-triggered qPCR (UPIP-qPCR) for SNP genotyping

10.6084/m9.figshare.17079118.v1figshare

Additional file 1 of Universal probe-based intermediate primer-triggered qPCR (UPIP-qPCR) for SNP genotyping

10.6084/m9.figshare.17079118figshare

Additional file 2 of Universal probe-based intermediate primer-triggered qPCR (UPIP-qPCR) for SNP genotyping

10.6084/m9.figshare.17079124.v1figshare

Additional file 2 of Universal probe-based intermediate primer-triggered qPCR (UPIP-qPCR) for SNP genotyping

10.6084/m9.figshare.17079124figshare

Additional file 5 of Universal probe-based intermediate primer-triggered qPCR (UPIP-qPCR) for SNP genotyping

10.6084/m9.figshare.17079133.v1figshare